Erythropoiesis-stimulating agents--time for a reevaluation

N Engl J Med. 2010 Jan 21;362(3):189-92. doi: 10.1056/NEJMp0912328. Epub 2010 Jan 6.
No abstract available

MeSH terms

  • Anemia / drug therapy*
  • Anemia / etiology
  • Cardiovascular Diseases / etiology*
  • Darbepoetin alfa
  • Diabetes Mellitus, Type 2 / complications
  • Epoetin Alfa
  • Erythropoietin / adverse effects
  • Erythropoietin / analogs & derivatives
  • Erythropoietin / therapeutic use
  • Hematinics / adverse effects*
  • Hematinics / therapeutic use
  • Hemoglobins
  • Humans
  • Recombinant Proteins
  • Renal Insufficiency, Chronic / complications*

Substances

  • Hematinics
  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin
  • Darbepoetin alfa
  • Epoetin Alfa